Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07204964) titled 'A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: GlaxoSmithKline
Condition:
Influenza, Human
Intervention:
Biological: Flu mRNA (Formulation B1)
Biological: Flu mRNA (Formulation B3)
Biological: Flu mRNA(Formulation A)
Combination Product: Comparator 1
Combination Product: Comparator 2
Recruitment Status: No...